
NYSE:KEYS
This summary was created by AI, based on 1 opinions in the last 12 months.
Keysight Technologies Inc. (KEYS-N) has received strong reviews as a leading measurement company in the quantum technology space, particularly noted for its part in developing the middle stack necessary for quantum inference. Experts emphasize the company's critical role in testing chips before they are launched into the market, positioning it as a major player in the tech landscape. Although the stock's 12-month price target is projected to be $403, it may appear expensive; however, analysts encourage investors to consider buying in increments at prices of $340 and $320. Despite the lack of dividends, the strong underlying fundamentals and market position make it an intriguing opportunity. Analysts have a consensus price target of $318.62, indicating potential for upside based on current valuations.
Keysight Technologies Inc. is a American stock, trading under the symbol KEYS (previously KEYS-N on Stockchase) on the New York Stock Exchange (KEYS). It is usually referred to as NYSE:KEYS or KEYS
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on KEYS (previously KEYS-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Keysight Technologies Inc..
Keysight Technologies Inc. was recommended as a Top Pick by Kim Bolton on 2026-05-06. Read the latest stock experts ratings for Keysight Technologies Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Keysight Technologies Inc..
Keysight Technologies Inc. is followed by 62 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-28, Keysight Technologies Inc. (KEYS) stock closed at a price of $305.17.
On the platform part of quantum -- middle part of the stack -- helps quantum make inferences. A measurement company, so it's one of the major players testing chips before they get rolled out.
(Analysts’ price target is $318.62)His 12-month price target is $403. May seem pricey, but keep it on your radar. Buy in thirds here, at $340, and at $320. No dividend.